Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma.
Mohan M, Kendrick S, Szabo A, Yarlagadda N, Atwal D, Pandey Y, Roy A, Parikh R, Lopez J, Thanendrarajan S, Schinke C, Alapat D, Sawyer J, Tian E, Tricot G, van Rhee F, Zangari M.
Mohan M, et al. Among authors: van rhee f.
Blood Adv. 2022 Feb 8;6(3):808-817. doi: 10.1182/bloodadvances.2021005822.
Blood Adv. 2022.
PMID: 34807986
Free PMC article.